Improved survival outcomes with the addition of rituximab to initial therapy for chronic lymphocytic leukemia: a comparative effectiveness analysis in the province of British Columbia, Canada

Lauren J. Lee; Cynthia L. Toze; Steven J. T. Huang; Tanya L. Gillan; Joseph M. Connors; Laurie H. Sehn; Helene Bruyere; Heather Leitch; Khaled M. Ramadan; Alina S. Gerrie

doi:10.1080/10428194.2017.1387904

Back

Improved survival outcomes with the addition of rituximab to initial therapy for chronic lymphocytic leukemia: a comparative effectiveness analysis in the province of British Columbia, Canada

Journal article

Peer reviewed

Improved survival outcomes with the addition of rituximab to initial therapy for chronic lymphocytic leukemia: a comparative effectiveness analysis in the province of British Columbia, Canada

Lauren J. Lee, Cynthia L. Toze, Steven J. T. Huang, Tanya L. Gillan, Joseph M. Connors, Laurie H. Sehn, Helene Bruyere, Heather Leitch, Khaled M. Ramadan and Alina S. Gerrie

Leukemia & lymphoma, Vol.59(6), pp.1356-1363

03/06/2018

DOI: https://doi.org/10.1080/10428194.2017.1387904

PMID: 29032719

Metrics

1 Record Views

See more details

Details

Title: Improved survival outcomes with the addition of rituximab to initial therapy for chronic lymphocytic leukemia: a comparative effectiveness analysis in the province of British Columbia, Canada
Creators - without role: Lauren J. Lee - University of British Columbia
Cynthia L. Toze - BC Cancer Agency
Steven J. T. Huang - University of British Columbia
Tanya L. Gillan - St. John’s Health Sciences Centre
Joseph M. Connors - BC Cancer Agency
Laurie H. Sehn - BC Cancer Agency
Helene Bruyere - Vancouver General Hospital
Heather Leitch - University of British Columbia
Khaled M. Ramadan - St. Paul's Hospital
Alina S. Gerrie - Vancouver General Hospital
Publication Details: Leukemia & lymphoma, Vol.59(6), pp.1356-1363
Identifiers: 9920087308331
Academic Unit: King Faisal University
Language: English
Resource Type: Journal article